April 1988
Advocate;4/12/88, Issue 496, Special Section p9
Reports that the Philip Mendelker AIDS Prevention Clinic is providing medical evaluation, health education and AIDS information at the Gay and Lesbian Community Services Center in Los Angeles, California.


Related Articles

  • Calendar: LOS ANGELES.  // Advocate;4/12/88, Issue 496, Special Section p9 

    Reports that the Philip Mendelker AIDS Prevention Clinic is providing medical evaluation, health education and AIDS information at the Gay and Lesbian Community Services Center in Los Angeles, California.

  • Studies Prove Antiretroviral Therapy Prevents HIV Infection.  // Bioworld Week;7/18/2011, Vol. 19 Issue 29, p5 

    The article reports on the studies that proved that the antiretroviral therapy decreased the HIV infection including the TDF2 study by Centers for Disease Control and Prevention (CDC) with Botswana Ministry of Health, and Partners pre-exposure prophylaxis (PrEP) study by University of Washington.

  • Trials Planned to Confirm Efficacy of Tenofovir Microbicide Gel. McEnery, Regina // VAX;Nov2010, Vol. 8 Issue 6, p3 

    The article reports on the plan to conduct two confirmatory trials on the efficacy of Tenofovir Microbicide Gel in preventing HIV infections, which will involve 3,000 women in South Africa.

  • NEW COMBINATION STUDIED.  // AIDS Patient Care & STDs;Mar2000, Vol. 14 Issue 3, p169 

    Reports that the AIDS Research Alliance in Los Angeles, California, is recruiting subjects for a small phase I/II trial of an antiretroviral combination. Investigation of the anti-malaria drug hydroxychloroquine; Antiviral activity exhibited by the drug.

  • Rational design of HIV vaccines and microbicides: report of the EUROPRISE network annual conference 2010. Brinckmann, Sarah; da Costa, Kelly; van Gils, Marit J.; Hallengärd, David; Klein, Katja; Madeira, Luisa; Mainetti, Lara; Palma, Paolo; Raue, Katharina; Reinhart, David; Reudelsterz, Marc; Ruffin, Nicolas; Seifried, Janna; Schäfer, Katrein; Sheik-Khalil, Enas; Sköld, Annette; Uchtenhagen, Hannes; Vabret, Nicolas; Ziglio, Serena; Scarlatti, Gabriella // Journal of Translational Medicine;2011, Vol. 9 Issue 1, p40 

    Novel, exciting intervention strategies to prevent infection with HIV have been tested in the past year, and the field is rapidly evolving. EUROPRISE is a network of excellence sponsored by the European Commission and concerned with a wide range of activities including integrated developmental...

  • The HVTN503/Phambili HIV vaccine trial: a comparison of younger and older participants. Volk, Jonathan E; Hessol, Nancy A; Gray, Glenda E; Kublin, James G; Churchyard, Gavin J; Mlisana, Koleka; Nchabeleng, Maphoshane; Buchbinder, Susan P; Bekker, Linda-Gail // International Journal of STD & AIDS;Apr2014, Vol. 25 Issue 5, p332 

    By comparing younger to older participants enrolled in a HIV vaccine efficacy trial, we aimed to gain insights into the inclusion of adolescents in future trials. This was a sub-analysis of a multisite HIV vaccine randomized clinical trial in South Africa, conducted January–September...

  • Understanding the Effects of Hormonal Contraception on HIV Transmission. McEnery, Regina // VAX;Nov2011, Vol. 9 Issue 6, p4 

    The article reports on the risks and benefits of using hormonal contraception in HIV prevention trials. It indicates that the mechanism of how hormonal contraception increased the risk of HIV infection is not clear. It suggests the importance of identifying the mechanisms that accelerate or...

  • Change in condom and other barrier method use during and after an HIV prevention trial in Zimbabwe. van der Straten, Ariane; Helen Cheng; Minnis, Alexandra M. // Journal of the International AIDS Society;2010, Vol. 13 Issue 1, p1 

    Background: We examined the use of male condoms and the diaphragm following completion of a clinical trial of the diaphragm's HIV prevention effectiveness. In the trial, called Methods for Improving Reproductive Health in Africa (MIRA), women were randomized to a diaphragm group (diaphragm, gel...

  • The continuing HIV vaccine saga: is a paradigm shift necessary? Smith, Kendall A. // Medical Immunology;2006, Vol. 5, p1 

    As pointed out in previous editorials, the development of an effective vaccine for the Human Immunodeficiency Virus capable of preventing infection, or even one capable of preventing the Acquired Immunodeficiency Disease Syndrome, has eluded investigators for the past 20 years. Now Reche and...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics